FDA NDC Directory · JSON-LD · Markdown

Zilretta

NDC 65250-003 · HUMAN PRESCRIPTION DRUG · KIT

Generic nametriamcinolone acetonide extended-release injectable suspension
Labeler / ManufacturerPacira Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208845
Dosage form / routeKIT · INTRA-ARTICULAR
Active ingredients—
Marketing started20171006
Package count1

External sources

Source: openFDA. Public-domain (CC0).